Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Masahiro Ishizaki"'
Autor:
Takaaki Tanaka, Ryosuke Ikeuchi, Kazuya Hisamatsu, Daisuke Mizuno, Taisaku Koyanagi, Toshiaki Morihiro, Takeshi Kurosaki, Futoshi Uno, Sae Wada, Hisaaki Tanaka, Hirofumi Tsugeno, Shinji Ozaki, Masahiro Ishizaki, Hideyuki Nishi, Nobukazu Fujimoto
Publikováno v:
Respiratory Medicine Case Reports, Vol 40, Iss , Pp 101781- (2022)
A 55-year-old man experienced nausea and vomiting after brushing his teeth. He experienced back pain after this episode and visited our emergency department. Chest computed tomography (CT) images revealed moderate pleural fluid accumulation and mild
Externí odkaz:
https://doaj.org/article/495734f9561240bcb2371e5f0bc66611
Publikováno v:
Journal of JSCE. 10:288-306
Autor:
Michio Nakamura, Fumiyo Maeda, Masahiro Ishizaki, Hideyuki Yanagisawa, Takayuki Yoshino, Masashi Fujii, Masato Nakamura, Masaki Kitazono, Yasuyuki Kawamoto, Akihito Tsuji, Hisatsugu Ohori, Tomoko Sonezaki, Hironaga Satake, Chihiro Komeno, Hidekazu Kuramochi, Yu Sunakawa, Masato Kataoka, Masahiro Takeuchi, Wataru Ichikawa
Publikováno v:
JCO Precision Oncology. :898-911
PURPOSE Several trials have evaluated the efficacy of rechallenge treatment with anti–epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) in patients with metastatic colorectal cancer (mCRC). A recent trial indicated that RAS status i
Publikováno v:
International Journal of Surgery Case Reports
Highlights • This is a case with the longest disease free interval after GIST surgery before metastasis to the liver. • Late liver metastasis can occur in the low risk group. • Our case was in the low risk group as per the Modified-Fletcher cla
Autor:
Kanto, Suemori, Futoshi, Uno, Kazuya, Hisamatsu, Daisuke, Mizuno, Shunsaku, Miyauchi, Norichika, Iga, Ryosuke, Yoshida, Hiroshi, Kawai, Masahiro, Ishizaki, Hideyuki, Nishi
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 49(1)
A 68-year-old man diagnosed with gastric mixed neuroendocrine-non-neuroendocrine neoplasia(MiNEN)concomitant with liver metastasis received chemotherapy using ramucirumab and paclitaxel. A decrease in tumor marker levels and size of the metastatic li
Autor:
Ryosuke, Yoshida, Daisuke, Mizuno, Kanto, Suemori, Shunsaku, Miyauchi, Norichika, Iga, Futoshi, Uno, Hiroshi, Kawai, Masahiro, Ishizaki, Hideyuki, Nishi, Kazuki, Yamashita
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 48(13)
A 70-year-old man with metastatic pancreatic ductal adenocarcinoma(cT4N1bM1, cStage Ⅳ)underwent chemotherapy with modified FOLFIRINOX without any severe adverse event to 20 cycles. In the middle of that, concurrent irradiation toward primary lesion
Autor:
Hiroshi, Kawai, Yuta, Imamura, Aoi, Kondoh, Daisuke, Mizuno, Kanto, Suemori, Syunsaku, Miyauchi, Norichika, Iga, Ryosuke, Yoshida, Futoshi, Uno, Masahiro, Ishizaki, Hideyuki, Nishi, Kazuki, Yamashita, Sinichiro, Miyohi
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 48(13)
A female in her 60s who complained of nipple discharge in her left breast for 1 year. A soft mass ill-defined margin in the border of AB area was observed. Mammography showed a focal asymmetric density. Ultrasonography disclosed an irregular heteroge
Publikováno v:
Journal of Japan Society of Civil Engineers, Ser. B1 (Hydraulic Engineering). 75:81-99
Autor:
Hideyuki, Nishi, Norichika, Iga, Shunsaku, Miyauchi, Ryousuke, Yoshida, Futoshi, Uno, Hiroshi, Kawai, Masahiro, Ishizaki
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 48(4)
When molecular target drug began to be used for chemotherapy to treat malignant pleural mesothelioma in 2014, we introduced this treatment strategy for 61 patients who were diagnosed and were being treated in our hospital. Chemotherapy was performed
[A Case of Unresectable Intrahepatic Cholangiocarcinoma Successfully Treated with Chemoradiotherapy]
Autor:
Ryosuke, Yoshida, Kanto, Suemori, Norichika, Iga, Futoshi, Uno, Hiroshi, Kawai, Masahiro, Ishizaki, Hideyuki, Nishi
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 47(13)
A 69-year-old woman with unresectable intrahepatic cholangiocarcinoma(T3N1M1, Stage Ⅳ)underwent chemoradiotherapy with gemcitabine, cisplatin and irradiation toward primary lesion(total dose, 36 Gy). Grade 3 or 4 adverse events include leukopenia,